Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
Vale, Claire L, Dr, Burdett, Sarah, MSc, Rydzewska, Larysa H M, BSc, Albiges, Laurence, MD, Clarke, Noel W, Prof, Fisher, David, MSc, Fizazi, Karim, Prof, Gravis, Gwenaelle, MD, James, Nicholas D, Prof, Mason, Malcolm D, Prof, Parmar, Mahesh K B, Prof, Sweeney, Christopher J, MBBS, Sydes, Matthew R, CStat, Tombal, Bertrand, Prof, Tierney, Jayne F, PhD
Published in The lancet oncology (01.02.2016)
Published in The lancet oncology (01.02.2016)
Get full text
Journal Article
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Maughan, Timothy S, Prof, Adams, Richard A, FRCP, Smith, Christopher G, BSc, Meade, Angela M, DPhil, Seymour, Matthew T, Prof, Wilson, Richard H, MD, Idziaszczyk, Shelley, MPhil, Harris, Rebecca, MSc, Fisher, David, MSc, Kenny, Sarah L, MSc, Kay, Edward, BA, Mitchell, Jenna K, BHSc, Madi, Ayman, MRCP, Jasani, Bharat, Prof, James, Michelle D, BSc, Bridgewater, John, MD, Kennedy, M John, MD, Claes, Bart, MSc, Lambrechts, Diether, PhD, Kaplan, Richard, Prof, Cheadle, Jeremy P, Prof
Published in The Lancet (British edition) (18.06.2011)
Published in The Lancet (British edition) (18.06.2011)
Get full text
Journal Article
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data
Mauguen, Audrey, MSc, Pignon, Jean-Pierre, Dr, Burdett, Sarah, MSc, Domerg, Caroline, MSc, Fisher, David, MSc, Paulus, Rebecca, BS, Mandrekar, Samithra J, PhD, Belani, Chandra P, Prof, Shepherd, Frances A, MD, Eisen, Tim, Prof, Pang, Herbert, PhD, Collette, Laurence, PhD, Sause, William T, MD, Dahlberg, Suzanne E, PhD, Crawford, Jeffrey, Prof, O'Brien, Mary, MD, Schild, Steven E, MD, Parmar, Mahesh, DPhil, Tierney, Jayne F, PhD, Pechoux, Cécile Le, MD, Michiels, Stefan, PhD
Published in The lancet oncology (01.06.2013)
Published in The lancet oncology (01.06.2013)
Get full text
Journal Article
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial
Wasan, Harpreet, MD, Meade, Angela M, Dr, Adams, Richard, MD, Wilson, Richard, MD, Pugh, Cheryl, BSc, Fisher, David, MSc, Sydes, Benjamin, Madi, Ayman, MD, Sizer, Bruce, MB, Lowdell, Charles, FRCP, Middleton, Gary, MD, Butler, Rachel, BSc, Kaplan, Richard, Prof, Maughan, Tim, Prof
Published in The lancet oncology (01.05.2014)
Published in The lancet oncology (01.05.2014)
Get full text
Journal Article
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Adams, Richard A, FRCP, Meade, Angela M, DPhil, Seymour, Matthew T, Prof, Wilson, Richard H, MD, Madi, Ayman, MRCP, Fisher, David, MSc, Kenny, Sarah L, MSc, Kay, Edward, BA, Hodgkinson, Elizabeth, BPharm, Pope, Malcolm, Rogers, Penny, BSc, Wasan, Harpreet, FRCP, Falk, Stephen, MD, Gollins, Simon, DPhil, Hickish, Tamas, MD, Bessell, Eric M, PhD, Propper, David, MD, Kennedy, M John, MD, Kaplan, Richard, Prof, Maughan, Timothy S, Prof
Published in The lancet oncology (01.07.2011)
Published in The lancet oncology (01.07.2011)
Get full text
Journal Article